Literature DB >> 4830233

Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.

B E Hopkins, R R Taylor.   

Abstract

The hemodynamic and phasic ascending aortic flow changes induced by acetylstrophanthidin and glucagon were studied in closed-chest sedated dogs with aortic regurgitation. While the positive inotropic effect of both agents was reflected in an increase in peak rate of rise of left ventricular pressure, acetylstrophanthidin increased aortic regurgitation, while glucagon decreased it. With the former, left ventricular end-diastolic pressure rose from 20+/-6 to 27+/-6 mm Hg (P < 0.005), but fell from 18+/-4 to 11+/-3 mm Hg (P < 0.001) with glucagon. Acetylstrophanthidin increased systemic vascular resistance, aortic diastolic pressure, and diastolic regurgitant flow rate, and, heart rate and the duration of regurgitation per beat and per minute being unchanged, regurgitant flow per beat increased 32+/-15% (P < 0.001). Glucagon decreased regurgitant flow per beat 27+/-14% (P < 0.001) because of abbreviation of diastole associated with tachycardia, and because of reduction in regurgitant flow rate. Despite tachycardia, the duration of regurgitation per minute was unchanged, and the small fall in regurgitant blood flow per minute was not significant, but this pertained in the face of 47% increase in effective cardiac output (P < 0.001). In contrast, acetylstrophanthidin increased regurgitant flow per minute 28+/-14% (P < 0.001) without change in effective cardiac output. The increase in cardiac contractility, tachycardia, and systemic vasodilatation induced by glucagon preferentially enhanced forward blood flow, which led to reduction in left ventricular volume overload, while it increased cardiac output. Contrarily, acetylstrophanthidin increased aortic regurgitation and, despite its inotropic effect, increased left ventricular volume overload without an increase in cardiac output.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4830233      PMCID: PMC302668          DOI: 10.1172/JCI107723

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Dynamics of the circulation in aortic valvular disease.

Authors:  R GORLIN; I K McMILLAN; W E MEDD; M B MATTHEWS; R DALEY
Journal:  Am J Med       Date:  1955-06       Impact factor: 4.965

2.  THE EFFECTS OF THE CARDIAC GLYCOSIDES UPON THE DYNAMICS OF THE CIRCULATION IN CONGESTIVE HEART FAILURE. I. OUABAIN.

Authors:  R A Bloomfield; B Rapoport; J P Milnor; W K Long; J G Mebane; L B Ellis; M R Lavin
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808

3.  STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE.

Authors:  E Braunwald; R D Bloodwell; L I Goldberg; A G Morrow
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

4.  Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.

Authors:  R Lvoff; D E Wilcken
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

5.  Left ventricular response to experimentally induced chronic aortic regurgitation.

Authors:  R R Taylor; B E Hopkins
Journal:  Cardiovasc Res       Date:  1972-07       Impact factor: 10.787

6.  Hemodynamic evaluation of glucagon in symptomatic heart disease.

Authors:  P W Armstrong; H K Gold; W M Daggett; W G Austen; C A Sanders
Journal:  Circulation       Date:  1971-07       Impact factor: 29.690

Review 7.  Oxygen consumption of the heart. Newer concepts of its multifactoral determination.

Authors:  E H Sonnenblick; J Ross; E Braunwald
Journal:  Am J Cardiol       Date:  1968-09       Impact factor: 2.778

8.  Myocardial infarction following coronary ligation in dogs. Hemodynamic effects of isoproterenol and acetylstrophanthidin.

Authors:  W B Hood; B McCarthy; B Lown
Journal:  Circ Res       Date:  1967-08       Impact factor: 17.367

9.  Cardiovascular effects of glucagon in man.

Authors:  J W Linhart; S S Barold; L S Cohen; F J Hildner; P Samet
Journal:  Am J Cardiol       Date:  1968-11       Impact factor: 2.778

10.  Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase.

Authors:  H K Gold; K H Prindle; G S Levey; S E Epstein
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

View more
  1 in total

1.  Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.

Authors:  B E Hockings; G D Cope; G M Clarke; R R Taylor
Journal:  Br Heart J       Date:  1980-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.